Source Medical, a leading provider of turnkey healthcare solutions and Yokogawa UK, announce a partnership that combines best in class technology and services to co-create value for the well-being of society through collaborative activities in the healthcare industry.
The partnership will combine Source Medical industry expertise and Yokogawa digital technologies to support the digital transformation of healthcare systems, improving laboratory and supply chain processes, lowering costs, and improving patient safety.
Yokogawa is pleased to form this partnership with Source Medical while supporting the healthcare sector and contributing to Sustainable Development Goal 3 ‘Good Health and Well-Being’ and Goal 17 ‘Partnerships for the Goals.’
On the 15th of September 2021, Source Medical, represented by CEO Ian Roberts, Quality Assurance and Regulatory Affairs Director Reanne Hamilton and Commercial Manager Varun Bitra and Yokogawa UK, represented by Managing Director Carl Ramsden and New Business and Digital Enterprise Solutions Manager Donal Bourke, finalised the Channel Partner Agreement.
About Source Medical
Source Medical is an independent UK-based Healthcare Procurement and Technology Solutions company, specialising in the provision of Turnkey Healthcare Solutions; and subsidiary of the Carbon 10 Group. Source Medical provides services to the NHS, Private Healthcare & Well-Being Organisations, Care Homes, and the Food Industry.
Source Medical focuses on alleviating the pain-points faced by healthcare organisations via introduction and implementation of innovative technology solutions, designed to enrich their customers’ decision-making processes with real-time data.
From tailored equipment standardisation and replacement programmes, to sourcing innovative technologies that aid clinical processes and relieve operational pressures; Source Medical are confident working with them will add value to all customers.
For more information about Source Medical, please visit www.sourcemed.co.uk
Founded in 1915, Yokogawa engages in broad-ranging activities in the areas of measurement, control, and information. The industrial automation business provides vital products, services, and solutions to a diverse range of process industries including oil, chemicals, natural gas, power, iron and steel, and pulp and paper. With the life innovation business, the company aims to radically improve productivity across the pharmaceutical and food industry value chains. The test & measurement, aviation, and other businesses continue to provide essential instruments and equipment with industry-leading precision and reliability. Yokogawa co-innovates with its customers through a global network of 114 companies spanning 62 countries, generating US$3.7 billion in sales in FY2019.
About Yokogawa Europe B.V.
The European headquarters of Yokogawa were founded in Amersfoort in the Netherlands in 1982. Throughout Europe Yokogawa has its own sales, service and engineering operations. This dedicated network has been extended to Central and East Europe to further enhance the coverage and support associated with serving the process control and automation marketplace. Yokogawa develops and produces flowmeters at Rota Yokogawa in Germany and liquid analyzers and industrial safety systems in the Netherlands. In addition to this dedicated network of Yokogawa subsidiaries, a select number of Channel Partners is established in certain areas to support specific customer needs of this continuously developing market.
Yokogawa is enabling innovation and digitalization of Europe’s pharmaceutical industry; ensuring stable and reliable supply of medicines to patients.